Converge Bio (Series A)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
January 13, 2026
Vertical
Biotechnology
Funding Amount
$25,000,000
Company Info
Founding Year
2024
Traction
Over a dozen pharma and biotech customers now use Converge's solutions.
Organizations Involved
Meta, OpenAI, Wiz
Founders
Dov Gertz, Iddo Weiner, Oded Kalev
Market
Pharmaceuticals
Location
Boston, MA, USA
Coinvestors
Bessemer Venture Partners, TLV Partners, Vintage Investment Partners, Saras Capital
Company Description

Converge Bio is an AI platform that enables biotech and pharmaceutical companies to accelerate drug discovery and development.

Links